HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomoo Itoh Selected Research

Squamous Cell Carcinoma (Epidermoid Carcinoma)

10/2013Immunohistochemical profiling of ALK fusion gene-positive adenocarcinomas of the lung.
12/2011Rapid multiplex immunohistochemistry using the 4-antibody cocktail YANA-4 in differentiating primary adenocarcinoma from squamous cell carcinoma of the lung.
1/2005Expression of N-acetylglucosaminyltransferase V in the development of human esophageal cancers: immunohistochemical data from carcinomas and nearby noncancerous lesions.
4/2003Predictive value of expression of P53, Bcl-2 and lung resistance-related protein for response to chemotherapy in non-small cell lung cancers.
5/2002Inverted papilloma of the nasal cavity presenting with massive amounts of squamous metaplastic cells in sputum. A case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomoo Itoh Research Topics

Disease

84Neoplasms (Cancer)
02/2024 - 02/2002
18Adenocarcinoma
01/2024 - 05/2002
14Carcinoma (Carcinomatosis)
01/2024 - 01/2000
12Neoplasm Metastasis (Metastasis)
04/2024 - 02/2002
12Cholangiocarcinoma
01/2021 - 01/2005
11Lung Neoplasms (Lung Cancer)
03/2022 - 04/2003
7Adenocarcinoma of Lung
03/2022 - 07/2006
7Hepatocellular Carcinoma (Hepatoma)
09/2019 - 02/2002
6Glioma (Gliomas)
01/2023 - 05/2013
6Lymphoma (Lymphomas)
01/2020 - 08/2003
6Carcinogenesis
09/2019 - 09/2002
5Fibrosis (Cirrhosis)
09/2023 - 06/2003
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2019 - 01/2007
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2013 - 05/2002
4Disease Progression
11/2023 - 10/2016
4Neonatal Hyperbilirubinemia
10/2017 - 10/2013
3Cysts
04/2024 - 11/2006
3Immunoglobulin G4-Related Disease
02/2024 - 03/2016
3Malignant Mesothelioma
12/2023 - 06/2003
3Mesothelioma
11/2023 - 06/2003
3Neuroendocrine Carcinoma
10/2023 - 07/2013
3Small Cell Lung Carcinoma (Small Cell Lung Cancer)
10/2023 - 07/2018
3Adenoma (Adenomas)
01/2022 - 11/2008
3Insulinoma
09/2020 - 05/2019
3Infections
01/2020 - 05/2011
3Pancreatic Neoplasms (Pancreatic Cancer)
11/2019 - 02/2007
3Sarcoma (Soft Tissue Sarcoma)
11/2019 - 11/2006
3Jaundice (Icterus)
09/2019 - 11/2008
3Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 11/2008
3Type 2 Diabetes Mellitus (MODY)
01/2018 - 06/2016
3Inflammation (Inflammations)
02/2016 - 01/2008
3Glioblastoma (Glioblastoma Multiforme)
06/2013 - 10/2003
2Pleural Effusion (Pleural Effusions)
11/2023 - 03/2020
2T-Cell Lymphoma (Lymphoma, T Cell)
01/2023 - 02/2004
2Splenomegaly
12/2020 - 09/2019
2Lymphadenopathy
12/2020 - 07/2014
2Adrenocortical Adenoma (Disease, Conn's)
09/2020 - 03/2020
2Atrophy
08/2020 - 07/2016
2Autoimmune Pancreatitis
08/2020 - 08/2017
2Graft vs Host Disease (Graft-Versus-Host Disease)
01/2020 - 05/2011
2Thrombosis (Thrombus)
11/2019 - 11/2018
2Ascites
11/2019 - 03/2004
2Membranous Glomerulonephritis (Membranous Nephropathy)
06/2019 - 07/2015
2Klatskin Tumor
01/2019 - 08/2018
2Liver Cirrhosis (Hepatic Cirrhosis)
11/2018 - 04/2012

Drug/Important Bio-Agent (IBA)

18Proteins (Proteins, Gene)FDA Link
12/2023 - 01/2002
9EnzymesIBA
01/2018 - 03/2004
7Immunoglobulin G (IgG)IBA
02/2024 - 07/2014
7Keratins (Keratin)IBA
12/2023 - 09/2002
6Biomarkers (Surrogate Marker)IBA
03/2022 - 08/2010
6AntigensIBA
09/2019 - 05/2002
6Messenger RNA (mRNA)IBA
09/2019 - 10/2003
6BilirubinIBA
10/2017 - 01/2007
5Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
01/2023 - 05/2013
5SteroidsIBA
08/2020 - 05/2011
5MucinsIBA
12/2016 - 01/2005
4Mucin-1 (CA 15-3 Antigen)IBA
12/2023 - 10/2002
45'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA
12/2023 - 03/2020
4CollagenIBA
10/2023 - 06/2003
4CytokinesIBA
01/2020 - 09/2015
4Interleukin-6 (Interleukin 6)IBA
09/2019 - 09/2009
4Prednisolone (Predate)FDA LinkGeneric
01/2019 - 01/2002
4Indicators and Reagents (Reagents)IBA
10/2016 - 01/2004
3ChromatinIBA
01/2024 - 06/2020
3alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2024 - 11/2016
3DesminIBA
12/2023 - 01/2017
3AsbestosIBA
11/2023 - 06/2003
3AcidsIBA
06/2021 - 01/2010
3Interleukin-10 (Interleukin 10)IBA
01/2020 - 09/2015
3Carcinoembryonic AntigenIBA
07/2013 - 01/2000
3GadoliniumIBA
05/2013 - 01/2012
3S100 Proteins (S 100 Protein)IBA
10/2012 - 01/2004
3DNA (Deoxyribonucleic Acid)IBA
05/2012 - 02/2002
2ThyroglobulinFDA Link
04/2024 - 01/2000
2GemcitabineFDA Link
10/2023 - 11/2019
2alpha-hydroxyglutarateIBA
01/2023 - 11/2016
2CateninsIBA
06/2021 - 12/2018
2beta CateninIBA
06/2021 - 11/2008
2Anti-Bacterial Agents (Antibiotics)IBA
04/2021 - 06/2003
2C-Reactive ProteinIBA
01/2021 - 02/2016
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2020 - 07/2018
2MART-1 AntigenIBA
03/2020 - 01/2017
2ChemokinesIBA
01/2020 - 01/2020
2Small Interfering RNA (siRNA)IBA
01/2020 - 01/2019
2Interleukin-33IBA
09/2019 - 08/2018
2Anaplastic Lymphoma KinaseIBA
05/2019 - 01/2019
2alectinibIBA
05/2019 - 01/2019
2Tyrosine Kinase InhibitorsIBA
05/2019 - 07/2013
2Monoclonal AntibodiesIBA
04/2019 - 01/2005
2Methotrexate (Mexate)FDA LinkGeneric
01/2019 - 01/2015

Therapy/Procedure

21Therapeutics
11/2023 - 10/2003
16Drug Therapy (Chemotherapy)
11/2019 - 04/2003
8Radiotherapy
11/2015 - 02/2004
4Transplantation
01/2020 - 04/2010
3Adrenalectomy
04/2024 - 03/2020
3Neoadjuvant Therapy
12/2023 - 02/2016
3Hepatectomy
11/2018 - 01/2005
3Aftercare (After-Treatment)
12/2015 - 03/2004
2Pancreaticoduodenectomy
01/2022 - 03/2019
2Esophagectomy
12/2018 - 02/2016